Cargando…

Human hybridoma and recombinant Pritumumab antibodies for treatment of human solid tumors

Detalles Bibliográficos
Autores principales:	Gupta, Rishab, Glassy, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288481/ http://dx.doi.org/10.1186/2051-1426-2-S3-P149

Ejemplares similares

Optimized fermentation conditions for improved antibody yield in hybridoma cells
por: Stützle, Martina, et al.
Publicado: (2013)

Production of monoclonal antibody, Anti-CD3 by hybridoma cells cultivated in Basket Spinner under free and immobilized conditions
por: Elsayed, Elsayed A, et al.
Publicado: (2013)

Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
por: Puligedda, Rama Devudu, et al.
Publicado: (2020)

Introducing a new chemically defined medium and feed for hybridoma cell lines
por: Heinrich, Christoph, et al.
Publicado: (2013)

CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study
por: Naing, Aung, et al.
Publicado: (2015)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells
Publicado: (1984)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Burris, Howard, et al.
Publicado: (2013)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Ansell, Stephen, et al.
Publicado: (2013)

Solubility evaluation of murine hybridoma antibodies
por: Spencer, Stacey, et al.
Publicado: (2012)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Human hybridomas from patients with malignant disease.
por: Sikora, K., et al.
Publicado: (1983)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Recombinant human proinsulin expression in Pichiapastoris using PGK promoter
por: de Assunçao, Enedina Nogueira, et al.
Publicado: (2014)

Alloimmunization with Cultured Human Stomach Cancer Cell Lines and the Establishment of Human‐Human Hybridomas Producing Monoclonal Antibodies
por: Koyama, Kotaro, et al.
Publicado: (1990)

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches
por: Crowe, James E.
Publicado: (2009)

Development of recombinant antibodies for reliable and sensitive food allergen detection
por: Haka, Jaana, et al.
Publicado: (2015)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015)

Safety and effectiveness of recombinant human growth hormone replacement in postoperative craniopharyngioma children
por: Zheng, Zhang-qian, et al.
Publicado: (2013)

Establishment and characterization of new human cell lines for recombinant therapeutic protein production
por: Inoue, Yuichi, et al.
Publicado: (2015)

Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen
Publicado: (1986)

Generation and Characterization of Mouse Hybridomas Secreting Monoclonal Antibodies Specific for Human IgG3
por: Hajighasemi, Fatemeh, et al.
Publicado: (2009)

Generation of the first monoclonal antibody using mouse hybridomas
por: Falini, Brunangelo
Publicado: (2022)

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013)

Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
por: Liacini, Abdelhamid, et al.
Publicado: (2014)

EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors
por: Ellwanger, Kristina, et al.
Publicado: (2015)

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Dose effects of recombinant human IL-11 on the systemic hemodynamic function in hemorrhagic shock
por: Honma, K, et al.
Publicado: (2007)

Antibodies against human influenza viruses in Galliformes order
por: Heydarchi, Behnaz, et al.
Publicado: (2011)

Analysis of T cell hybridomas. IV. Characterization of inducible suppressor cell hybridomas
Publicado: (1983)

Recombinant biosynthesis of functional human growth hormone and coagulation factor IX in transgenic soybean seeds
por: da Cunha, Nicolau Brito, et al.
Publicado: (2014)

Simple and precise targeted editing of the human genome using rAAV-mediated homologous recombination
por: Torrance, Christopher J
Publicado: (2012)

Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
por: Lambert, Caroline A, et al.
Publicado: (2015)

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
por: Matsuno, H, et al.
Publicado: (2003)

A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.
por: Haines, A. M., et al.
Publicado: (1989)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_09155tpkmidjggk9uc2hnqpv3j